Viral protease-initiated lytic cell death as a universal antiviral mRNA therapy.

July 20, 2026| Source: Cell

While gasdermin (GSDM)-mediated pyroptosis is a potent immune effector, its antiviral potential remains largely untapped. Here, we introduce viral protease-initiated lytic cell death (VID), a universal mRNA therapeutic platform inspired by the modular architecture of GSDM and the clinical success of mRNA vaccines. By engineering gasdermin-D (GSDMD) to harbor viral protease-specific cleavage motifs, we generated VID activators (VIDAs) that selectively trigger lytic cell death in virus-infected cells. Using hepatitis A virus (HAV) as a model, lipid nanoparticle (LNP)-encapsulated VIDA mRNA abolished viral replication and shedding in vivo and mitigated liver injury through a coordinated "kill-and-alert" mechanism that primes bystander immunity. The platform's versatility was further demonstrated against Zika virus (ZIKV) and SARS-CoV-2. Leveraging a generative artificial intelligence (AI) framework, we designed de novo cleavage motifs for the SARS-CoV-2 main protease, yielding optimized VIDAs with superior antiviral potency. Collectively, our study establishes VIDA mRNA as a versatile, broadly applicable strategy for combating diverse viral threats.

Read the original source →

Plant fiber exploitation contributed to the emergence of ground-edged cutting tools in North China.

Ground-edged cutting tools are widely regarded as technological hallmarks of early agriculture in North China, commonly hypothesized to have been developed primarily for cereal harvesting. Yet the functional foundations of this innovation remain insufficiently tested. This study integrates use-wear and microfossil analyses of 140 stone tools from the Peiligang site, with experimental data, to reassess their roles within long-term trajectories of technological change from the Late Paleolithic to

Artificial IntelligenceSeptember 28, 2026

Neural network-augmented Pfaffian wave-functions for scalable simulations of interacting fermions.

Developing accurate numerical methods for strongly interacting fermions is crucial for improving our understanding of various quantum many-body phenomena, especially unconventional superconductivity. Recently, neural quantum states have emerged as a promising approach for studying correlated fermions, highlighted by the hidden fermion and backflow methods, which use neural networks to model corrections to fermionic quasiparticle orbitals. In this work, we expand these ideas to the space of Pfaff

Artificial IntelligenceSeptember 26, 2026

Why friends in common reveal network stars.

The Friendship Paradox states that, on average, your friends have more friends than you do. We extend this to common friends-those who appear in multiple people's friend lists. We show that the more people who share a common friend, the more connected that person tends to be, and we derive an expression quantifying this progression. In a regional Facebook network, a common friend to three randomly sampled individuals has on average more friends than 99.9% of the network. In a citation network, a

Artificial IntelligenceSeptember 26, 2026

Sensory context improves language prediction in humans and LLMs.

Language is a fundamental human capacity. Large language models (LLMs) have presented the first viable model of language outside of humans, yet how these models learn and use language differs significantly from humans. Here, we compare LLMs and humans predicting language with varying levels of sensory information-from disembodied written text to audiovisual videos of speakers-to demonstrate that, in both humans and LLMs, sensory context is critical for optimal performance. We asked human partici

Artificial IntelligenceSeptember 10, 2026

Treatment Decisions in Multiple Myeloma.

Revolutions in transplantation and targeted and immune therapies have transformed multiple myeloma from a disease with an associated survival of a few years into one for which functional cure is an emerging goal. This abundance of effective therapies has created clinical complexity. Here we provide a practical framework, anchored in trial evidence and informed by emerging biologic discoveries, for the navigation of treatment decisions across the disease spectrum. We outline how cytogenetic and g